Asia Pacific IV Equipment Market (2026-2031)
The Asia Pacific IV Equipment Market was valued at $3875.4 Million in 2026 and projected to reach to $5310.5 Million by 2031, representing a compound annual growth rate of 6.5%. The Asia Pacific IV Equipment Market is positioned for sustained expansion through 2031, driven by increasing healthcare expenditure, growing patient populations, and rapid urbanization across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific IV Equipment Market Trends and Insights
- Asia Pacific's 6.5% compound annual growth rate outpaces the global average, driven by rising healthcare infrastructure investments and increasing patient populations across the region.
- The market in Asia Pacific is benefiting from expanding hospital networks, growing adoption of advanced infusion technologies, and heightened demand for home-based care solutions. Asia Pacific's IV equipment sector is characterized by rapid modernization and regulatory improvements that enhance market accessibility.
- Between 2026 and 2031, Asia Pacific is expected to capture significant market share through increased manufacturing capacity and regional supply chain development.
- Key markets within Asia Pacific, including China, India, Japan, and Southeast Asia, are driving innovation in infusion pump technology and safety-focused delivery systems. The competitive landscape in Asia Pacific reflects both multinational presence and emerging local manufacturers.
- Asia Pacific's market dynamics are shaped by cost-consciousness, regulatory harmonization efforts, and strategic partnerships that strengthen distribution networks across the region..
Key Market Statistics
- CAGR (2026-2031) 6.5% CAGR
- Market Size, 2026 ~USD 3875.4 Million
- Forecast, 2031 ~USD 5310.5 Million
- Geography Asia Pacific
Asia Pacific IV Equipment Market Overview
Regional Growth Outpacing Global Average :
Asia Pacific's IV Equipment Market is expanding at 6.5% CAGR, surpassing the global rate of 6.1%, reflecting strong regional demand and healthcare modernization initiatives across emerging and developed economies.
China Leads Market Expansion :
China dominates the Asia Pacific IV Equipment Market with $774.68 million in market size, driven by massive healthcare infrastructure investments, rising hospitalization rates, and increasing adoption of advanced medical technologies.
Significant Growth Trajectory :
The market is projected to grow from $3,875.4 million in 2026 to $5,310.5 million by 2031, representing a $1,435.1 million increase and demonstrating sustained investment in healthcare delivery systems across the region.
Diverse Market Composition :
Asia Pacific comprises diverse economies from Japan ($512M) and India ($291.93M) to emerging markets like Vietnam ($46.88M) and Thailand ($58.12M), offering varied growth opportunities across different development stages.
Asia Pacific IV Equipment Market Dynamics
- Countries like China, Japan, and India are investing heavily in hospital infrastructure and medical device adoption, creating robust demand for IV equipment.
- Emerging economies are modernizing their healthcare systems, while developed markets are upgrading to advanced infusion technologies. Key growth catalysts include rising prevalence of chronic diseases, expanding geriatric populations, and government healthcare initiatives.
- The region's competitive manufacturing landscape and cost advantages are attracting both local and international players.
- Strategic partnerships, regulatory improvements, and technological innovation in IV delivery systems will further accelerate market penetration across Asia Pacific through 2031..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Asia Pacific IV Equipment Market will grow from $3,875.4M (2026) to $5,310.5M (2031) at a 6.5% CAGR, outpacing global growth rates.
- Asia Pacific's expanding healthcare infrastructure and rising patient populations are primary catalysts for IV equipment demand through 2031.
- Asia Pacific is witnessing increased adoption of advanced infusion technologies and home-based care solutions driving market expansion.
- Asia Pacific's competitive landscape combines multinational players with emerging local manufacturers, supported by improving regulatory frameworks.
IV Equipment Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | NEEDLE-FREE CONNECTORS & EXTENSION SETS (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.1% from 2026 to 2031 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 17.79 (2026) |
| Revenue Forecast (Billions) | ~USD 23.92 (2031) |
| Segments Covered | Type, Application, End User |
Asia Pacific IV Equipment Market Report Segmentation
3 segment dimensions are covered across the global market.
By Type
- Analgesia/Pain Management
- Antibiotic/Antimicrobial Iv Therapy
- Critical Care & Vasoactive Drug Infusion
- Critical Care Nutrition
- Gastrointestinal Disorders
- Immunotherapy
- Infusion Pumps
- Iv Administration Sets & Tubing
- Iv Catheters
- Iv Drip Chambers
- Needle-Free Connectors & Extension Sets
- Neonatal & Pediatric Parenteral Nutrition
- Oncology (Iv Chemotherapy)
- Other Blood & Blood Products Transfusion Applications
- Other Iv Equipment
- Other Parenteral Nutrition Applications
- Plasma Transfusion
- Platelet Transfusion
- Red Blood Cell Transfusion
- Securement & Stabilization Devices
- Sedation & Anesthesia Infusion
By Application
- Blood & Blood Products Transfusion
- Diagnostic Testing
- Fluid & Electrolyte Replacement
- Medication Administration
- Other Applications
- Parenteral Nutrition (Pn)
By End User
- Ambulatory Surgical Centers
- Ambulatory Surgical Centers (Ascs)
- Home Care Settings
- Hospitals
- Other End Users
- Outpatient Infusion & Specialty Clinics
Target Audience
- Medical Device Manufacturers : IV equipment producers need Asia Pacific market intelligence to identify expansion opportunities, assess competitive positioning, and develop region-specific product strategies across diverse healthcare markets.
- Healthcare Investors & PE Firms : Investment professionals require detailed market sizing, growth forecasts, and country-level analysis to evaluate acquisition targets, portfolio companies, and capital allocation decisions in Asia Pacific healthcare.
- Hospital & Healthcare Facility Operators : Healthcare administrators need market insights to benchmark procurement strategies, evaluate supplier options, and plan equipment investments aligned with regional market trends and pricing dynamics.
- Distributors & Supply Chain Partners : Distribution companies require regional market data to optimize inventory management, identify growth markets, negotiate supplier agreements, and develop channel strategies across Asia Pacific territories.
- Government & Healthcare Policy Makers : Policy officials and healthcare planners need market analysis to inform healthcare infrastructure investments, procurement policies, and regulatory frameworks supporting IV equipment accessibility across Asia Pacific.
Key Companies in the Asia Pacific IV Equipment Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Long-term acute care hospital drug utilization,Inpatient rehabilitation facility drug utilization,Contract rehabilitation and ancillary services, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Pre- and post-automation services,Contract manufacturing and value engineering, |
| CONVATEC | United Kingdom | Public Company | Advanced wound care,Ostomy care,Continence and critical care, |
| IRADIMED CORPORATION | United States | Public Company | MRidium 3870/3860+ MRI-compatible infusion pump systems and disposables,3880 MRI-compatible patient vital signs monitoring system and accessories,3600 FMD1 ferromagnetic detection devices and remote alarm units, |
| POLY MEDICURE LTD. | India | Public Company | Infusion & Transfusion Therapy,Critical Care & Anesthesia/Respiratory,Dialysis & Renal Care, |
| CONMED CORPORATION | United States | Public Company | Sports medicine & soft tissue fixation (BioBrace, Y-Knot, TruShot, Agro Knotless),Powered large & small bone systems (Hall brand),General surgery – insufflation & smoke management (AirSeal, Buffalo Filter), |
| MALLINCKRODT PLC | Ireland | Private Company | Autoimmune and rare disease therapies,Neurology and rheumatology specialty products,Neonatal respiratory and critical care therapies, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (syringes, needles, catheters, sharps, specimen collection),Connected Care (infusion, medication management, automation, informatics),BioPharma Systems (prefillable drug delivery, CSTD, hazardous drug detection), |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV solutions, infusion systems, parenteral nutrition, dialysis-related therapies),Healthcare Systems & Technologies (smart beds, OR integration, monitoring, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services), |
| FRESENIUS SE & CO. KGAA | Germany | Public Company | Fresenius Helios (hospitals and outpatient care),IV generics and IV fluids,Clinical nutrition (enteral and parenteral), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion pumps and hardware,Infusion consumables and vascular access (Clave, Neutron, Tego, disinfection caps),IV solutions and diluents, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| MOOG, INC. | United States | Public Company | Military Aircraft,Commercial Aircraft,Space and Defense, |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular access & emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck clips, MiniLap, staplers, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS), |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | China | Public Company | Patient monitoring, anesthesia, ventilators, and life-support,Ultrasound and medical imaging (radiology, emergency, critical care),In-vitro diagnostics (CLIA, chemistry, hematology), |
| CARDINAL HEALTH | United States | Public Company | Pharmaceutical Distribution (Branded & Generic),Specialty Pharmaceutical & Manufacturer Services,Medical Products & Cardinal-Branded Devices, |
| AVANOS MEDICAL, INC. | United States | Public Company | Digestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA), |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products), |
| JMS CO., LTD. | United States | Public Company | U.S. Retail Coffee,U.S. Retail Pet Foods and Snacks,U.S. Retail Frozen Handheld and Spreads, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a private United States-based healthcare company founded in 1985 with 64,200 employees. The company operates healthcare facilities and provides related medical services.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
CONVATEC
ConvaTec is a United Kingdom-based public company founded in 1978. The company manufactures and distributes medical devices and healthcare products globally.
IRADIMED CORPORATION
IraMed Corporation is a United States-based public company founded in 1992 with 166 employees. The company specializes in medical imaging and monitoring equipment.
POLY MEDICURE LTD.
Poly Medicure Ltd. is an Indian public company founded in 1995 with 3,082 employees. The company manufactures medical devices and healthcare products.
CONMED CORPORATION
ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company manufactures and distributes surgical and medical devices.
MALLINCKRODT PLC
Mallinckrodt PLC is an Ireland-based private company with a history dating to 1867 and 2,687 employees. The company operates in the pharmaceutical and medical device sectors.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. The company is a global leader in medical technology, manufacturing diagnostic and healthcare devices.
BAXTER
Baxter is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures medical devices, pharmaceuticals, and healthcare solutions.
FRESENIUS SE & CO. KGAA
Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. The company is a global healthcare company providing dialysis, infusion therapy, and hospital products.
ICU MEDICAL, INC.
ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures critical care medical devices and infusion therapy products.
TERUMO CORPORATION
Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices and healthcare products globally.
MOOG, INC.
Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.
TELEFLEX INCORPORATED
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care and surgical applications.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company manufactures medical devices and diagnostic equipment.
CARDINAL HEALTH
Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. The company is a global healthcare services and products company serving hospitals and healthcare providers.
AVANOS MEDICAL, INC.
Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company manufactures and distributes medical devices for healthcare applications.
NIPRO
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures medical devices, pharmaceuticals, and healthcare products.
JMS CO., LTD.
JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company manufactures medical devices and healthcare products.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 774.68 Million |
| Japan | USD 512 Million |
| India | USD 291.93 Million |
| South Korea | USD 96.02 Million |
| Australia | USD 114.77 Million |
| Philippines | USD 17.48 Million |
| Malaysia | USD 37.87 Million |
| Vietnam | USD 46.88 Million |
| Singapore | USD 28.39 Million |
| Indonesia | USD 30.55 Million |
| Thailand | USD 58.12 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for Asia Pacific ($3,875.4M in 2026) and country-level breakdowns including China, Japan, India, and emerging markets, with detailed 5-year projections through 2031.
- Competitive Landscape Intelligence : Understand market dynamics specific to Asia Pacific, including key players, market share distribution, and competitive strategies tailored to regional healthcare systems and regulatory environments.
- Growth Driver Analysis : Identify region-specific growth catalysts such as healthcare infrastructure investments, rising chronic disease prevalence, aging populations, and government healthcare initiatives driving 6.5% CAGR.
- Country-Level Investment Opportunities : Evaluate market potential across 11 Asia Pacific countries with varying maturity levels, from established markets like Japan and Australia to high-growth emerging economies like Vietnam and India.
- Strategic Market Entry Planning : Develop targeted go-to-market strategies with insights into regulatory requirements, reimbursement models, distribution channels, and customer preferences specific to Asia Pacific healthcare systems.
Frequently asked questions
What is the projected market size for IV Equipment in Asia Pacific by 2031?
Asia Pacific's IV Equipment Market is projected to reach $5,310.5 million by 2031, growing from $3,875.4 million in 2026.
What is the CAGR for the Asia Pacific IV Equipment Market?
Asia Pacific's IV Equipment Market is expected to grow at a compound annual growth rate of 6.5% between 2026 and 2031.
Which countries are driving growth in Asia Pacific's IV Equipment Market?
Key markets within Asia Pacific including China, India, Japan, and Southeast Asia are driving innovation and market expansion in IV equipment.
What factors are accelerating IV Equipment demand in Asia Pacific?
Asia Pacific's IV equipment demand is accelerated by expanding healthcare infrastructure, rising patient populations, advanced infusion technology adoption, and growing home-based care solutions.
How does Asia Pacific's IV Equipment Market growth compare to global trends?
Asia Pacific's 6.5% CAGR outpaces the global IV Equipment Market CAGR of 6.1%, indicating stronger regional growth momentum through 2031.
RESEARCH METHODOLOGY
This study relied heavily on both primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and company SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IV equipment market. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the IV equipment market. The primary demand-side sources include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.
Breakdown of Primary Interviews:
A breakdown of the primary respondents for the IV equipment market (supply side) is provided below:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion,
Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In this report, the global IV equipment market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the IV equipment business were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.
To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involved the following steps:
- Generating a list of major global players operating in the IV equipment market
- Mapping annual revenues generated by major global players from the IV equipment segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the IV equipment industry
Global IV Equipment Market Size: Top-down & Bottom-up Approach
IV Equipment Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size through the market size estimation process explained above, the global IV equipment market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the IV equipment market was validated using both top-down and bottom-up approaches.
Market Definition
IV equipment refers to the complete set of medical devices, accessories, and consumables used to deliver fluids, medications, nutrients, and blood products directly into a patient’s bloodstream through intravenous (IV) access. It includes infusion pumps, IV administration sets, catheters and cannulas, needle-free connectors, extension sets, securement devices, and related safety components designed to ensure accurate, controlled, and sterile delivery of therapies in hospitals, outpatient centers, and home care settings. IV equipment is essential for hydration, drug infusion, chemotherapy, parenteral nutrition, anesthesia, critical care, and emergency treatment.
Key Stakeholders
- Manufacturers of IV equipment
- Distributors of IV equipment
- Hospitals, clinics, and infusion centers
- Ambulatory surgery centers
- Non-government organizations
- Government regulatory authorities
- Contract manufacturers & third-party suppliers
- Research laboratories & academic institutes
- Clinical research organizations (CROs)
- Government & non-governmental regulatory authorities
- Market research & consulting firms
Report Objectives
- To define, describe, and forecast the IV equipment market based on type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global IV equipment market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global IV equipment market
- To analyze key growth opportunities in the global IV equipment market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the global IV equipment market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the global IV equipment market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global IV equipment market, such as agreements, collaborations, partnerships, expansions, and acquisitions
Customization Options
Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the present global IV equipment market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies
Company Information
- Detailed analysis and profiling of additional market players (up to 10)
Geographic Analysis
- Further breakdown of the Rest of Europe IV equipment market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, and Belgium
- Further breakdown of the Rest of Asia Pacific IV equipment market into Taiwan, New Zealand, and Sri Lanka
- Further breakdown of the Rest of Latin America IV equipment market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay
Get the Full IV Equipment Market Report
Full forecast, segment splits, and company analysis for all IV Equipment Market.
- US IV Equipment Market
- Canada IV Equipment Market
- Germany IV Equipment Market
- UK IV Equipment Market
- France IV Equipment Market
- Italy IV Equipment Market
- Spain IV Equipment Market
- Netherlands IV Equipment Market
- Denmark IV Equipment Market
- Sweden IV Equipment Market
- China IV Equipment Market
- Japan IV Equipment Market
- India IV Equipment Market
- South Korea IV Equipment Market
- Australia IV Equipment Market
- Philippines IV Equipment Market
- Malaysia IV Equipment Market
- Vietnam IV Equipment Market
- Singapore IV Equipment Market
- Indonesia IV Equipment Market
- Thailand IV Equipment Market
- Brazil IV Equipment Market
- Mexico IV Equipment Market
- Argentina IV Equipment Market
- Colombia IV Equipment Market
- Chile IV Equipment Market
- Peru IV Equipment Market
- Rest Of Europe IV Equipment Market
- Rest Of Asia Pacific IV Equipment Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report